The global Asthma & COPD market size was valued at US$ million in 2023. With growing demand in downstream market, the Asthma & COPD is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Asthma & COPD market. Asthma & COPD are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Asthma & COPD. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Asthma & COPD market.
Chronic obstructive pulmonary disease (COPD) is a general term that describes progressive respiratory diseases like emphysema and chronic bronchitis. COPD is characterized by decreased airflow over time, as well as inflammation of the tissues that line the airway.
Asthma is usually considered a separate respiratory disease, but sometimes it鈥檚 mistaken for COPD. The two have similar symptoms. These symptoms include chronic coughing, wheezing, and shortness of breath.
Currently, North America leads the global market for asthma & COPD drugs and devices. North America was followed by Europe in terms of market capitalization. However, North America and Europe is expected to lose out some of the market share to other emerging regional markets owing to the expiry of several patens of pharmaceutical companies operating in these regions. Asia Pacific is expected to be the fastest regional market for asthma and COPD owing to the increased incidence of asthma & other respiratory diseases in industrial regions.
Key Features:
The report on Asthma & COPD market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Asthma & COPD market. It may include historical data, market segmentation by Type (e.g., Anti-inflammatory Drugs, Bronchodilator Monotherapy), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Asthma & COPD market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Asthma & COPD market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Asthma & COPD industry. This include advancements in Asthma & COPD technology, Asthma & COPD new entrants, Asthma & COPD new investment, and other innovations that are shaping the future of Asthma & COPD.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Asthma & COPD market. It includes factors influencing customer ' purchasing decisions, preferences for Asthma & COPD product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Asthma & COPD market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Asthma & COPD market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Asthma & COPD market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Asthma & COPD industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Asthma & COPD market.
Market Segmentation:
Asthma & COPD market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Anti-inflammatory Drugs
Bronchodilator Monotherapy
Combination Drugs
Segmentation by application
Hospital Pharmacies
Private Clinics
Drug Stores
Retail Pharmacies
E-Commerce
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GSK
Novartis
Merck
Abbott
Boehringer Ingelheim
AstraZeneca
Roche
Teva
Vectura
Pfizer
Mylan
Allergan
Cipla
Akorn
Key Questions Addressed in this Report
What is the 10-year outlook for the global Asthma & COPD market?
What factors are driving Asthma & COPD market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Asthma & COPD market opportunities vary by end market size?
How does Asthma & COPD break out type, application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Asthma & COPD Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Asthma & COPD by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Asthma & COPD by Country/Region, 2019, 2023 & 2030
2.2 Asthma & COPD Segment by Type
2.2.1 Anti-inflammatory Drugs
2.2.2 Bronchodilator Monotherapy
2.2.3 Combination Drugs
2.3 Asthma & COPD Sales by Type
2.3.1 Global Asthma & COPD Sales Market Share by Type (2019-2024)
2.3.2 Global Asthma & COPD Revenue and Market Share by Type (2019-2024)
2.3.3 Global Asthma & COPD Sale Price by Type (2019-2024)
2.4 Asthma & COPD Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Private Clinics
2.4.3 Drug Stores
2.4.4 Retail Pharmacies
2.4.5 E-Commerce
2.5 Asthma & COPD Sales by Application
2.5.1 Global Asthma & COPD Sale Market Share by Application (2019-2024)
2.5.2 Global Asthma & COPD Revenue and Market Share by Application (2019-2024)
2.5.3 Global Asthma & COPD Sale Price by Application (2019-2024)
3 Global Asthma & COPD by Company
3.1 Global Asthma & COPD Breakdown Data by Company
3.1.1 Global Asthma & COPD Annual Sales by Company (2019-2024)
3.1.2 Global Asthma & COPD Sales Market Share by Company (2019-2024)
3.2 Global Asthma & COPD Annual Revenue by Company (2019-2024)
3.2.1 Global Asthma & COPD Revenue by Company (2019-2024)
3.2.2 Global Asthma & COPD Revenue Market Share by Company (2019-2024)
3.3 Global Asthma & COPD Sale Price by Company
3.4 Key Manufacturers Asthma & COPD Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Asthma & COPD Product Location Distribution
3.4.2 Players Asthma & COPD Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Asthma & COPD by Geographic Region
4.1 World Historic Asthma & COPD Market Size by Geographic Region (2019-2024)
4.1.1 Global Asthma & COPD Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Asthma & COPD Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Asthma & COPD Market Size by Country/Region (2019-2024)
4.2.1 Global Asthma & COPD Annual Sales by Country/Region (2019-2024)
4.2.2 Global Asthma & COPD Annual Revenue by Country/Region (2019-2024)
4.3 Americas Asthma & COPD Sales Growth
4.4 APAC Asthma & COPD Sales Growth
4.5 Europe Asthma & COPD Sales Growth
4.6 Middle East & Africa Asthma & COPD Sales Growth
5 Americas
5.1 Americas Asthma & COPD Sales by Country
5.1.1 Americas Asthma & COPD Sales by Country (2019-2024)
5.1.2 Americas Asthma & COPD Revenue by Country (2019-2024)
5.2 Americas Asthma & COPD Sales by Type
5.3 Americas Asthma & COPD Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Asthma & COPD Sales by Region
6.1.1 APAC Asthma & COPD Sales by Region (2019-2024)
6.1.2 APAC Asthma & COPD Revenue by Region (2019-2024)
6.2 APAC Asthma & COPD Sales by Type
6.3 APAC Asthma & COPD Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Asthma & COPD by Country
7.1.1 Europe Asthma & COPD Sales by Country (2019-2024)
7.1.2 Europe Asthma & COPD Revenue by Country (2019-2024)
7.2 Europe Asthma & COPD Sales by Type
7.3 Europe Asthma & COPD Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Asthma & COPD by Country
8.1.1 Middle East & Africa Asthma & COPD Sales by Country (2019-2024)
8.1.2 Middle East & Africa Asthma & COPD Revenue by Country (2019-2024)
8.2 Middle East & Africa Asthma & COPD Sales by Type
8.3 Middle East & Africa Asthma & COPD Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Asthma & COPD
10.3 Manufacturing Process Analysis of Asthma & COPD
10.4 Industry Chain Structure of Asthma & COPD
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Asthma & COPD Distributors
11.3 Asthma & COPD Customer
12 World Forecast Review for Asthma & COPD by Geographic Region
12.1 Global Asthma & COPD Market Size Forecast by Region
12.1.1 Global Asthma & COPD Forecast by Region (2025-2030)
12.1.2 Global Asthma & COPD Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Asthma & COPD Forecast by Type
12.7 Global Asthma & COPD Forecast by Application
13 Key Players Analysis
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Asthma & COPD Product Portfolios and Specifications
13.1.3 GSK Asthma & COPD Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis Asthma & COPD Product Portfolios and Specifications
13.2.3 Novartis Asthma & COPD Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Asthma & COPD Product Portfolios and Specifications
13.3.3 Merck Asthma & COPD Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Abbott
13.4.1 Abbott Company Information
13.4.2 Abbott Asthma & COPD Product Portfolios and Specifications
13.4.3 Abbott Asthma & COPD Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Abbott Main Business Overview
13.4.5 Abbott Latest Developments
13.5 Boehringer Ingelheim
13.5.1 Boehringer Ingelheim Company Information
13.5.2 Boehringer Ingelheim Asthma & COPD Product Portfolios and Specifications
13.5.3 Boehringer Ingelheim Asthma & COPD Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Boehringer Ingelheim Main Business Overview
13.5.5 Boehringer Ingelheim Latest Developments
13.6 AstraZeneca
13.6.1 AstraZeneca Company Information
13.6.2 AstraZeneca Asthma & COPD Product Portfolios and Specifications
13.6.3 AstraZeneca Asthma & COPD Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 AstraZeneca Main Business Overview
13.6.5 AstraZeneca Latest Developments
13.7 Roche
13.7.1 Roche Company Information
13.7.2 Roche Asthma & COPD Product Portfolios and Specifications
13.7.3 Roche Asthma & COPD Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Roche Main Business Overview
13.7.5 Roche Latest Developments
13.8 Teva
13.8.1 Teva Company Information
13.8.2 Teva Asthma & COPD Product Portfolios and Specifications
13.8.3 Teva Asthma & COPD Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Teva Main Business Overview
13.8.5 Teva Latest Developments
13.9 Vectura
13.9.1 Vectura Company Information
13.9.2 Vectura Asthma & COPD Product Portfolios and Specifications
13.9.3 Vectura Asthma & COPD Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Vectura Main Business Overview
13.9.5 Vectura Latest Developments
13.10 Pfizer
13.10.1 Pfizer Company Information
13.10.2 Pfizer Asthma & COPD Product Portfolios and Specifications
13.10.3 Pfizer Asthma & COPD Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Pfizer Main Business Overview
13.10.5 Pfizer Latest Developments
13.11 Mylan
13.11.1 Mylan Company Information
13.11.2 Mylan Asthma & COPD Product Portfolios and Specifications
13.11.3 Mylan Asthma & COPD Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Mylan Main Business Overview
13.11.5 Mylan Latest Developments
13.12 Allergan
13.12.1 Allergan Company Information
13.12.2 Allergan Asthma & COPD Product Portfolios and Specifications
13.12.3 Allergan Asthma & COPD Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Allergan Main Business Overview
13.12.5 Allergan Latest Developments
13.13 Cipla
13.13.1 Cipla Company Information
13.13.2 Cipla Asthma & COPD Product Portfolios and Specifications
13.13.3 Cipla Asthma & COPD Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Cipla Main Business Overview
13.13.5 Cipla Latest Developments
13.14 Akorn
13.14.1 Akorn Company Information
13.14.2 Akorn Asthma & COPD Product Portfolios and Specifications
13.14.3 Akorn Asthma & COPD Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Akorn Main Business Overview
13.14.5 Akorn Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
